Trials / Completed
CompletedNCT02927626
Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma
Clinical Research of Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma Basing on Immune Microenviroment
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- Beijing Ditan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Clinical research of Yang Yin Fu Zheng therapy in HBV associated hepatocellular carcinoma basing on immune microenviroment.The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng therapy for patients belong to HBV-HCC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Yang Yin Fu Zheng therapy | Yang Yin Fu Zheng is a Chinese herbal compound. |
| DRUG | Routine medical care | Routine medical care |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2016-10-07
- Last updated
- 2020-07-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02927626. Inclusion in this directory is not an endorsement.